News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  1st February 2012  
  Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin
 
 




Authors
Manjeet Mukherjee1,+, Soah Yee Chow2,+, Permeen Yusoff2, J. Seetharaman4, Cherlyn Ng2, Saravanan Sinniah2, Xiao Woon Koh2, Nur Farehan M. Asgar2, Dan Li2, Daniel Yim2, Rebecca A. Jackson2, Jingxi Yew2, Jingru Qian5, Audrey Iyu2, Yoon Pin Lim,3 Xingding Zhou1, Siu Kwan Sze5, Graeme R. Guy2* and J. Sivaraman1*

1 - Department of Biological Sciences, National University of Singapore
2 - Signal Transduction Laboratory, Institute of Molecular and Cell Biology
3 - Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore
4 - X4 beamline, Brookhaven National Laboratory, USA
5 - School of Biological Sciences, Nanyang Technological University
*Corresponding authors
+Joint first authors

  
Published in EMBO Journal, 17 January 2012. (Epub ahead of print.)

Abstract
Phosphotyrosine-binding domains, typified by the SH2 and PTB domains, are critical upstream components of signal transduction pathways. The E3 ubiquitin ligase Hakai targets tyrosine phosphorylated E-cadherin via an uncharacterized domain. In this study, the crystal structure of Hakai (aa 106-206) revealed that it forms an atypical, zinc-coordinated homodimer by utilizing residues from the phosphotyrosine-binding domain of two Hakai monomers. Hakai dimerization allows the formation of a phosphotyrosine-binding pocket that recognizes specific phosphorylated tyrosines and flanking acidic amino acids of Src substrates, such as E-cadherin, cortactin and DOK1. NMR and mutational analysis identified the Hakai residues required for target binding within the binding pocket, now named the HYB domain. ZNF645 also possesses a HYB domain but demonstrates different target specificities. The HYB domain is structurally different from other phosphotyrosine-binding domains and is a potential drug target due to its novel structural features.


Figure 1 Legend: The Hakai dimer forms an intertwined, anti-parallel configuration spanning the points indicated in circles, with the entry and exit paths shown in green and brown arrows. The zinc-interacting side-chains are shown as green and brown sticks. Zinc-coordination takes place with the amino acid residues C172, H185 and H190 from one Hakai monomer and C166 from the other monomeric partner.





Figure 2 Legend: Immunoprecipitates of either wild-type Hakai or the Hakai zinc-coordinating mutants were tested for interaction with its endogenous substrate, cortactin. In the absence of Hakai dimerization with the zinc-coordinating mutants, the interaction with cortactin does not occur.





Figure 3 Legend: Six potential residues in Hakai were identified through NMR studies to interact with its substrate E-cadherin, and are highlighted as sticks in the ribbon representation of the crystal structure.